American College of Cardiology

NOVEMBER 16, 2024

The goal of the BPROAD trial was to determine the efficacy and safety of an intensive blood pressure (BP)-lowering strategy in patients with type 2 diabetes mellitus (T2DM) and hypertension with respect to future cardiovascular disease (CVD) events.

Blood Pressure 40

Blood Pressure Diabetes Cardiovascular Disease Hypertension 40

CardiacWire

SEPTEMBER 13, 2024

Nearly half of American adults have hypertension, and a new JAMA study reveals that the vast majority of them don’t have their blood pressure under control, while most don’t even know they have the disease. adults have hypertension, while uncontrolled hypertension is associated with $131B-$198B in annual healthcare costs.

Hypertension 52

Hypertension Blood Pressure Risk Factors Patient Care 52

Frontiers in Cardiovascular Medicine

DECEMBER 20, 2023

Objectives To determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the IBERICAN cohort. This analysis shows the baseline clinical characteristics of patients with hypertension.

Blood Pressure 134

Blood Pressure Hypertension Obesity Risk Factors 134

Medical Xpress - Cardiology

JULY 1, 2024

Eating patterns that align with the Mediterranean diet or the dietary approaches to stop hypertension (DASH) diet could help lower cardiovascular disease risk in adults with type 1 diabetes, according to results from a six-year study.

Diabetes 66

Diabetes Diet Research Cardiovascular Disease 66

Heart BMJ

OCTOBER 10, 2024

The frequent concurrence of elevated blood pressure (BP) and type 2 diabetes markedly elevates the risk of cardiovascular disease and mortality. The review introduces a mediation model, delineating the intricate interplay between hypertension and diabetes and their joint contribution to cardiovascular and renal pathologies.

Blood Pressure 52

Blood Pressure Diabetes Pharmacology Cardiovascular Disease 52

Hypertension Journal

NOVEMBER 22, 2023

Hypertension, Ahead of Print. However, diabetic comorbid conditions, such as nocturnal hypertension, as predictors of diastolic dysfunction are not known in the absence of an HF period. BACKGROUND:Diabetes is an important risk factor for heart failure (HF) and is associated with left ventricular (LV) diastolic dysfunction.

Hypertension 40

Hypertension Heart Failure Diabetes Risk Factors 40

HCPLive

APRIL 29, 2024

Key Opinion Leaders address the psychiatric issues associated with hypercortisolism and highlight crucial clinical symptoms to look for when diagnosing the condition, such as hypertension in patients under 30 without a family history, diabetes in those under 40 with no family history, and bone issues among other signs.

Diabetes 52

Diabetes Hypertension 52

DAIC

MAY 8, 2024

Bioelectronic medicine scientists at The Feinstein Institutes for Medical Research used noninvasive, splenic focused ultrasound stimulation (sFUS) and found they can reduce inflammation and improve symptoms of pulmonary arterial hypertension (PAH).

Ultrasound 115

Ultrasound Pulmonary Research Hypertension 115

Cardiovascular Diabetology

APRIL 9, 2024

Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often acc.

Kidney Disease 64

Kidney Disease Hypertension Public Health Diabetes 64

HCPLive

OCTOBER 4, 2024

An EADV 2024 study suggests dupilumab use during pregnancy is generally safe and may lower risks of preterm labor, gestational hypertension, and diabetes.

Hypertension 110

Hypertension Diabetes Outcomes 110

Circulation

NOVEMBER 11, 2024

Introduction:Obesity is rising in prevalence worldwide and co-exists in patients with group 1 pulmonary hypertension (PH). After accounting for age, gender, diabetes mellitus and systemic hypertension, the RAP, cardiac output, PAC and PCWP remained significantly higher, and PVR remained lower in obese patients (p<0.05

Obesity 40

Obesity Pulmonary Hypertension Diabetes 40

Hypertension Journal

DECEMBER 7, 2023

Hypertension, Ahead of Print. ETs were shown to play important roles among others, in systemic hypertension, particularly when resistant or difficult to control, and in pulmonary hypertension, atherosclerosis, cardiac hypertrophy, subarachnoid hemorrhage, chronic kidney disease, diabetic cardiovascular disease, scleroderma, some cancers, etc.

Kidney Disease 45

Kidney Disease Hypertension Pulmonary Atherosclerosis 45

Cardiometabolic Health Congress

JULY 10, 2024

Bakris , an internationally recognized and influential nephrologist and hypertension expert, who passed away on June 15, 2024, at the age of 72. Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression.

Hypertension 52

Hypertension Education Blood Pressure Kidney Disease 52

DAIC

JANUARY 19, 2024

The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. Orchestra BioMed and Medtronic, Inc. Kowal, M.D., and Europe.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

Frontiers in Cardiovascular Medicine

JULY 21, 2024

BackgroundThis Mendelian randomization (MR) study aimed to explore the causal relationship between the genetic predisposition to type 2 diabetes mellitus (T2DM) and aortic dissection (AD), and to assess associations with genetically predicted glycemic traits. For AD data, FinnGen Release 10 was used, including 967 cases and 381,977 controls.

Genetic predisposition 59

Genetic predisposition Diabetes Aortic Coronary Artery Disease 59

Cardiovascular Diabetology

AUGUST 11, 2024

We evaluated the prevalence of “heart stress” (HS) based on NT-proBNP cut-points proposed by the 2023 Consensus of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in asymptomati.

Blood Pressure 111

Blood Pressure Heart Failure Hypertension Diabetes 111

Hypertension Journal

MAY 14, 2024

Hypertension, Volume 81, Issue 6 , Page 1269-1271, June 1, 2024.

Hypertension 40

Hypertension Diabetes 40

CardiacWire

OCTOBER 27, 2024

Heart Disease in 2050 – The AHA warned of massive heart disease increases by 2050, spanning CVD (+60%), diabetes (+100%), obesity (+70%), hypertension (+44%), heart failure (+66%), and stroke (+100%). Hypertension Problems: Another JAMA study highlighted the U.S.’s s massive hypertension diagnosis and treatment problems.

AFIB 59

AFIB Hypertension Kidney Disease Heart Disease 59

HCPLive

OCTOBER 30, 2024

A decade after bariatric surgery, most teens maintained weight loss and reduced obesity-related conditions such as type 2 diabetes and hypertension.

Obesity 59

Obesity Hypertension Diabetes 59

Hypertension Journal

NOVEMBER 8, 2023

Hypertension, Ahead of Print. Alterations in microcirculation play a crucial role in the pathogenesis of cardiovascular and metabolic disorders such as obesity and hypertension. The interrelationship between obesity and hypertension could be explained, at least in part, by a cross-talk between microcirculation and PVAT.

Obesity 40

Obesity Hypertension Blood Pressure Article 40

Stroke Journal

FEBRUARY 1, 2024

There is a critical lack of data about early life stroke risk factors among Black women, a group with higher rates of hypertension compared to other racial groups. Using Cox models, we estimated risk of midlife stroke, comparing persons with and without hypertension before age 45, between ages 45-64, and at 10-year age intervals.

Hypertension 40

Hypertension Strokes Stroke Public Health 40

Stroke Journal

FEBRUARY 1, 2024

There is a critical lack of data about early life stroke risk factors among Black women, a group with higher rates of hypertension compared to other racial groups. Using Cox models, we estimated risk of midlife stroke, comparing persons with and without hypertension before age 45, between ages 45-64, and at 10-year age intervals.

Hypertension 40

Hypertension Strokes Stroke Public Health 40

HeartRhythm

MARCH 12, 2024

Diabetes mellitus (DM) is a public health problem that continues to grow worldwide. 2 As noted elsewhere,3 DM and AF affect a population that shares concomitant conditions such as obesity, hypertension and even heart failure (HF). In the United States the Center for Disease Control and Prevention estimates that it affects 11.6%

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Public Health Obesity 40

Hypertension Journal

OCTOBER 11, 2023

Hypertension, Volume 80, Issue 12 , Page 2591-2600, December 1, 2023. RESULTS:The median age of the patients was 76 years, and 54.9% were women. The total AHT incidence was 70 cases per 100 000 admission year. Urgent dialysis rates increased from 1.52% (95% CI, 1.12–2.06) 2.06) to 2.60% (2.17–3.1;

Hypertension 40

Hypertension Kidney Disease Heart Failure Risk Factors 40

Journal of the American Heart Association

DECEMBER 12, 2023

BackgroundThis real‐world evaluation considers an algorithm designed to detect patients with potentially undiagnosed hypertension, receiving routine care, in a large health system in Hawaiʻi. had been diagnosed with hypertension, 2.7% had no evidence of hypertension. Among the eligible patients (N=13 364), 52.6%

Hypertension 45

Hypertension COVID-19 Medicaid Medicare 45

Hypertension Journal

OCTOBER 13, 2023

Hypertension, Volume 80, Issue 12 , Page 2581-2590, December 1, 2023. BACKGROUND:This study aimed to develop a risk-scoring model for hypertension among Africans.METHODS:In this study, 4413 stroke-free controls were used to develop the risk-scoring model for hypertension. for the training set and 64.6% (95% CI, 61.0–68.0)

Hypertension 40

Hypertension BMI Risk Factors Education 40

Hypertension Journal

JANUARY 8, 2024

Hypertension, Ahead of Print. RESULTS:Thirteen, 11, and 7 trials were eligible for systolic and diastolic BP difference and BP control, respectively.

Blood Pressure 81

Blood Pressure Diabetes Hypertension Nursing 81

HCPLive

AUGUST 21, 2024

Medical experts discuss the implications of finding hypercortisolism in one-third of patients on three or more hypertension medications, the linkage between hypercortisolism and type 2 diabetes as presented in the ‘Pathologic Mechanisms of Hypercortisolism in Type 2 Diabetes’ session, and how hypercortisolism affects diabetes management, including (..)

Diabetes 52

Diabetes Hypertension 52

CardiacWire

MAY 8, 2024

Officially published by the AHA six months ago, CKM syndrome defines the connections and risks associated with obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. Stage 2 (metabolic risk factors like hypertension, diabetes, CKD) – 49% Stage 3 (kidney disease or high cardiovascular risks) – 5.4%

Kidney Disease 116

Kidney Disease Obesity Risk Factors Diabetes 116

Circulation

NOVEMBER 11, 2024

of senior patients with age-related diseases such as hypertension, dyslipidemia and atrial fibrillation had PVTs, as estimated by cardiac computed tomography (CT) and transesophageal echocardiography (TEE). Patients with type 2 diabetes mellitus (T2DM) must have PVTs. Pulmonary vein thrombi (PVTs) are common and are underestimated.

Pulmonary 45

Pulmonary Diabetes Atrial Fibrillation Hypertension 45

Circulation

NOVEMBER 11, 2024

Randomized controlled trials that were published between January 1st, 2013 and May 1st, 2023 that included hypertensive patients over 60 years old which reported major adverse cardiovascular outcomes (MACE) or all-cause mortality, cardiovascular mortality and safety outcomes were selected. diabetes, and 15.5% chronic kidney disease.

Blood Pressure 40

Blood Pressure Hypertension Kidney Disease Outcomes 40

Dr. Smith's ECG Blog

DECEMBER 10, 2022

I was texted this ECG by one of my partners, with the following history: A 60-something male with diabetes and HTN presented with syncope. Per EMS report, the patient had a syncopal episode at work.

Diabetes 52

Diabetes Hypertension Blog Cardiomyopathy 52

Open Heart

MAY 23, 2024

Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. Hypertension and diabetes were independent risk factors for pre-eclampsia. It is not known whether heart failure increases the risk of pre-eclampsia.

Heart Disease 98

Heart Disease Heart Failure Risk Factors Obesity 98

Med Page Today

APRIL 3, 2024

(MedPage Today) -- Using a personalized algorithm to identify primary care patients with chronic kidney disease (CKD), type 2 diabetes, and hypertension (the kidney-dysfunction triad) -- plus practice facilitators to help providers deliver guideline.

Kidney Disease 75

Kidney Disease Hospital Hypertension Diabetes 75

Cardiometabolic Health Congress

OCTOBER 30, 2024

November is National Diabetes Month , and with the increasing overlap between type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH) , it’s critical to focus on integrating liver health into the management of cardiometabolic patients.

Diabetes 93

Diabetes Exercise Obesity BMI 93

Circulation

OCTOBER 13, 2023

BACKGROUND:Apparent treatment-resistant hypertension (aTRH) is prevalent and associated with adverse outcomes in heart failure with mildly reduced or preserved ejection fraction. Nonresistant hypertension was defined as BP above threshold but not meeting aTRH criteria. per 100 patient-years) compared with nonresistant hypertension (2.7

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Hypertension Myocardial Infarction 40

Cardiometabolic Health Congress

NOVEMBER 14, 2024

42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. In the U.S., SELECT Trial Results : Semaglutide 2.4

CME 96

CME Obesity Heart Failure Biomarkers 96